165 results
Page 3 of 9
8-K
EX-99.1
e2jj6 sl3
24 Feb 22
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:14pm
8-K
EX-99.1
cqnbepvck291udk
15 Feb 22
Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
4:02pm
8-K
EX-99.1
jyzzh
1 Dec 21
Vaxart Announces Acquisition of Second GMP Manufacturing Facility
4:00pm
8-K
EX-99.1
vkij zktri
4 Nov 21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
tni9w0nti
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-99.1
uoeje63
5 Aug 21
Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
4:08pm
8-K
1h3ygu g51qhsm5btp
2 Aug 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
wpvo19
9 Jul 21
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
4:02pm
8-K
t9d2k63 n3u4
3 May 21
Other Events
1:23pm
8-K
EX-99.1
5uangpdav6pp eyd2h
23 Apr 21
Vaxart Appoints David Wheadon, M.D., to its Board of Directors
4:00pm
8-K
EX-99.1
rekwk1f0lj3a4dr
25 Feb 21
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:04pm